Related Experiment Video

Updated: Sep 20, 2025

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

24.8K

Interventions for adult congenital heart disease

Pedro Cepas-Guillén1, Eduardo Flores-Umanzor2, Eric Horlick3

  • 1Quebec Heart & Lung Institute, Laval University, Quebec City, Quebec, Canada.

Nature Reviews. Cardiology
|January 20, 2025
PubMed

Insights

Transcatheter interventions offer a less invasive option for adults with congenital heart disease (CHD). This review details current transcatheter procedures, indications, and outcomes for complex adult CHD, enhancing awareness among cardiologists.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Adult Congenital Heart Disease

Background:

  • Improved treatments for paediatric congenital heart disease (CHD) have led to increased survival and a growing adult population with complex CHD.
  • Transcatheter interventions are increasingly used as an alternative to open-heart surgery for congenital defects.
  • There is a need to improve awareness of adult CHD interventions among the general cardiology community.

Purpose of the Study:

  • To provide a comprehensive evaluation of transcatheter interventions for adult patients with complex congenital heart disease.
  • To highlight the evolution of techniques, devices, and operator experience in treating adult CHD.
  • To inform the broader cardiology community about clinical indications and outcomes of these interventions.

Main Methods:

  • Review of contemporary transcatheter interventions for adult congenital heart disease.
  • Evaluation of clinical indications and associated outcomes.
  • Synthesis of current knowledge on techniques and devices.

Main Results:

  • Transcatheter interventions are a viable and evolving alternative to surgery for adult CHD.
  • Advances in technology and expertise allow treatment of increasingly complex cases.
  • Outcomes data are crucial for guiding clinical decision-making.

Conclusions:

  • Transcatheter interventions are a cornerstone in managing adult congenital heart disease.
  • Continued research and education are vital to optimize patient care.
  • This review serves as a resource for understanding current transcatheter options for adult CHD.

More Related Videos

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA13:10

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA

Published on: April 24, 2017

18.7K
A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn11:27

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn

Published on: April 7, 2023

6.5K

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
42
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
40
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
149
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
40
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
34
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
69